{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:22:35Z","timestamp":1787026955585,"version":"build-2736575974"},"reference-count":110,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,4,2]],"date-time":"2020-04-02T00:00:00Z","timestamp":1585785600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"DOI":"10.3389\/fonc.2020.00422","type":"journal-article","created":{"date-parts":[[2020,4,2]],"date-time":"2020-04-02T00:35:54Z","timestamp":1585787754000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":22,"title":["Integrating Biological Advances Into the Clinical Management of Breast Cancer Related Lymphedema"],"prefix":"10.3389","volume":"10","author":[{"given":"Marco","family":"Invernizzi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluca","family":"Lopez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Michelotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos","family":"Venetis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elham","family":"Sajjadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leticia","family":"De Mattos-Arruda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Ghidini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Letterio","family":"Runza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"de Sire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renzo","family":"Boldorini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Fusco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,4,2]]},"reference":[{"key":"B1","unstructured":"The increasing role of lymphedema screening, diagnosis and management as part of evidence-based guidelines for breast cancer care3589 ViciniF ShahC ArthurD 10.1111\/tbj.1258626929240Breast J.222016"},{"key":"B2","unstructured":"The grading of lymphedema in oncology clinical trials21425 ChevilleAL McGarveyCL PetrekJA RussoSA ThiadensSR TaylorME 10.1016\/S1053-4296(03)00038-9Semin Radiat Oncol.132003"},{"key":"B3","unstructured":"Worse and worse off: the impact of lymphedema on work and career after breast cancer657 BoyagesJ KalfaS XuY KoelmeyerL MackieH ViverosH 10.1186\/s40064-016-2300-827330922Springerplus52016"},{"key":"B4","unstructured":"Diagnostic methods, risk factors, prevention, and management of breast cancer-related lymphedema: past, present, and future directions11121 SayeghHE AsdourianMS SwaroopMN BrunelleCL SkolnyMN SalamaL 10.1007\/s12609-017-0237-828894513Curr Breast Cancer Rep92017"},{"key":"B5","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1111\/j.1445-2197.2008.04686.x","article-title":"Comparison of volume displacement versus circumferential arm measurements for lymphoedema: implications for the SNAC trial","volume":"78","author":"Tewari","year":"2008","journal-title":"ANZ J Surg"},{"key":"B6","unstructured":"Measurement properties of instruments for measuring of lymphedema: systematic review196581 HiddingJT ViehoffPB BeurskensCH van LaarhovenHW Nijhuis-van der SandenMW van der WeesPJ 10.2522\/ptj.2015041227340195Phys Ther962016"},{"key":"B7","unstructured":"Bioimpedance spectroscopy for breast cancer related lymphedema assessment: clinical practice guidelines64550 ShahC ViciniFA ArthurD 10.1111\/tbj.1264727487985Breast J222016"},{"key":"B8","unstructured":"Tackling the diversity of breast cancer related lymphedema: perspectives on diagnosis, risk assessment, and clinical management1523 MichelottiA InvernizziM LopezG LorenziniD NesaF De SireA 10.1016\/j.breast.2018.12.00930580170Breast442019"},{"key":"B9","unstructured":"Integrating augmented reality tools in breast cancer related lymphedema prognostication and diagnosis InvernizziM RunzaL De SireA LippiL BlundoC GambiniD 10.3791\/6009332090996J Vis Exp.2020"},{"key":"B10","doi-asserted-by":"publisher","first-page":"e392","DOI":"10.1016\/S1470-2045(16)30204-2","article-title":"Precautions for breast cancer-related lymphoedema: risk from air travel, ipsilateral arm blood pressure measurements, skin puncture, extreme temperatures, and cellulitis","volume":"17","author":"Asdourian","year":"2016","journal-title":"Lancet Oncol"},{"key":"B11","unstructured":"Lymphatic microsurgical preventing healing approach (LYMPHA) for primary surgical prevention of breast cancer-related lymphedema: over 4 years follow-up4214 BoccardoF CasabonaF De CianF DeCianF FriedmanD MurelliF 10.1002\/micr.2225424677148Microsurgery342014"},{"key":"B12","doi-asserted-by":"crossref","unstructured":"Manual lymphatic drainage for lymphedema following breast cancer treatment EzzoJ ManheimerE McNeelyML HowellDM WeissR JohanssonKI 10.1002\/14651858.CD003475.pub225994425Cochrane Database Syst Rev2015","DOI":"10.1002\/14651858.CD003475.pub2"},{"key":"B13","unstructured":"Liposuction in Lymphedema Treatment5665 BrorsonH 10.1055\/s-0035-1549158J Reconstr Microsurg322016"},{"key":"B14","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1200\/JCO.2015.64.3809","article-title":"American Cancer Society\/American Society of Clinical Oncology Breast Cancer survivorship care guideline","volume":"34","author":"Runowicz","year":"2016","journal-title":"J Clin Oncol"},{"key":"B15","unstructured":"Supermicrosurgical deep lymphatic vessel-to-venous anastomosis for a breast cancer-related arm lymphedema with severe sclerosis of superficial lymphatic vessels1569 YamamotoT YamamotoN HayashiA KoshimaI 10.1002\/micr.2238225597913Microsurgery372017"},{"key":"B16","volume-title":"Gray's Anatomy, The Anatomical Basis of Clinical Practice","author":"Standring","year":"2015"},{"key":"B17","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/nature14425","article-title":"Lymphatic vessels arise from specialized angioblasts within a venous niche","volume":"522","author":"Nicenboim","year":"2015","journal-title":"Nature"},{"key":"B18","doi-asserted-by":"publisher","first-page":"5452","DOI":"10.3390\/ijms20215452","article-title":"Targeting immune-related biological processes in solid tumors: we do need biomarkers","volume":"20","author":"Pagni","year":"2019","journal-title":"Int J Mol Sci"},{"key":"B19","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.1101\/gad.216226.113","article-title":"The Prox1-Vegfr3 feedback loop maintains the identity and the number of lymphatic endothelial cell progenitors","volume":"28","author":"Srinivasan","year":"2014","journal-title":"Genes Dev"},{"key":"B20","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/S0092-8674(00)81511-1","article-title":"Prox1 function is required for the development of the murine lymphatic system","volume":"98","author":"Wigle","year":"1999","journal-title":"Cell"},{"key":"B21","doi-asserted-by":"publisher","first-page":"3282","DOI":"10.1101\/gad.1727208","article-title":"Lymphatic endothelial cell identity is reversible and its maintenance requires Prox1 activity","volume":"22","author":"Johnson","year":"2008","journal-title":"Genes Dev"},{"key":"B22","doi-asserted-by":"publisher","first-page":"2372","DOI":"10.1182\/blood-2004-07-2547","article-title":"Roles of vascular endothelial growth factor receptor 3 signaling in differentiation of mouse embryonic stem cell-derived vascular progenitor cells into endothelial cells","volume":"105","author":"Suzuki","year":"2005","journal-title":"Blood"},{"key":"B23","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/ni1013","article-title":"Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins","volume":"5","author":"Karkkainen","year":"2004","journal-title":"Nat Immunol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/978-3-7091-1646-3_8","article-title":"Platelets in lymph vessel development and integrity","volume":"214","author":"Watson","year":"2014","journal-title":"Adv Anat Embryol Cell Biol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1152\/physrev.00037.2011","article-title":"Interstitial fluid and lymph formation and transport: physiological regulation and roles in inflammation and cancer","volume":"92","author":"Wiig","year":"2012","journal-title":"Physiol Rev"},{"key":"B26","doi-asserted-by":"publisher","first-page":"2368","DOI":"10.1161\/ATVBAHA.110.217281","article-title":"Platelets: covert regulators of lymphatic development","volume":"30","author":"Bertozzi","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"3997","DOI":"10.1182\/blood-2009-04-216069","article-title":"Novel function for blood platelets and podoplanin in developmental separation of blood and lymphatic circulation","volume":"115","author":"Uhrin","year":"2010","journal-title":"Blood"},{"key":"B28","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1172\/JCI70422","article-title":"Platelets mediate lymphovenous hemostasis to maintain blood-lymphatic separation throughout life","volume":"124","author":"Hess","year":"2014","journal-title":"J Clin Invest"},{"key":"B29","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.devcel.2009.06.017","article-title":"Integrin-alpha9 is required for fibronectin matrix assembly during lymphatic valve morphogenesis","volume":"17","author":"Bazigou","year":"2009","journal-title":"Dev Cell"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.1242\/dev.089565","article-title":"Getting out and about: the emergence and morphogenesis of the vertebrate lymphatic vasculature","volume":"140","author":"Koltowska","year":"2013","journal-title":"Development"},{"key":"B31","unstructured":"FOXC2 haploinsufficient mice are a model for human autosomal dominant lymphedema-distichiasis syndrome117985 KriedermanBM MyloydeTL WitteMH DagenaisSL WitteCL RennelsM 12719382Hum Mol Genet122003"},{"key":"B32","unstructured":"Foxc2 is expressed in developing lymphatic vessels and other tissues associated with lymphedema-distichiasis syndrome6119 DagenaisSL HartsoughRL EricksonRP WitteMH ButlerMG GloverTW 10.1016\/j.modgep.2004.07.00415465483Gene Expr Patterns42004"},{"key":"B33","unstructured":"Defective valves and abnormal mural cell recruitment underlie lymphatic vascular failure in lymphedema distichiasis97481 PetrovaTV KarpanenT Norrm\u00e9nC MellorR TamakoshiT FinegoldD 10.1038\/nm109415322537Nat Med102004"},{"key":"B34","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1111\/j.1749-6632.2002.tb04878.x","article-title":"Physiologic aspects of lymphatic contractile function: current perspectives","volume":"979","author":"Gashev","year":"2002","journal-title":"Ann N Y Acad Sci"},{"key":"B35","unstructured":"Lymphatic smooth muscle: the motor unit of lymph drainage114753 von der WeidPY ZawiejaDC 10.1016\/j.biocel.2003.12.00815109561Int J Biochem Cell Biol362004"},{"key":"B36","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.1084\/jem.20062596","article-title":"Functionally specialized junctions between endothelial cells of lymphatic vessels","volume":"204","author":"Baluk","year":"2007","journal-title":"J Exp Med"},{"key":"B37","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/(SICI)1097-0185(199701)247:1<53::AID-AR8>3.0.CO;2-G","article-title":"The structure of superficial lymphatics in the human thigh: precollectors","volume":"247","author":"Sacchi","year":"1997","journal-title":"Anat Rec"},{"key":"B38","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.pharmthera.2004.10.009","article-title":"Current topics of physiology and pharmacology in the lymphatic system","volume":"105","author":"Ohhashi","year":"2005","journal-title":"Pharmacol Ther"},{"key":"B39","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1111\/j.1469-7580.2010.01215.x","article-title":"The structure and mechanical properties of collecting lymphatic vessels: an investigation using multimodal nonlinear microscopy","volume":"216","author":"Arkill","year":"2010","journal-title":"J Anat"},{"key":"B40","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1017\/S0022215112002939","article-title":"The surgical anatomy and clinical relevance of the neglected right lymphatic duct: review","volume":"127","author":"Smith","year":"2013","journal-title":"J Laryngol Otol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.thorsurg.2011.01.002","article-title":"Anatomy of the thoracic duct","volume":"21","author":"Hematti","year":"2011","journal-title":"Thorac Surg Clin."},{"key":"B42","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1097\/PRS.0b013e3182450b2d","article-title":"Regulation of adipogenesis by lymphatic fluid stasis: part I. Adipogenesis, fibrosis, and inflammation","volume":"129","author":"Zampell","year":"2012","journal-title":"Plast Reconstr Surg"},{"key":"B43","unstructured":"Timing of lymphedema following treatment for breast cancer: when are patients most at-risk?6270 McDuffSGR MinaAI BrunelleCL SalamaL WarrenLEG AbouegylahM 10.1016\/j.ijrobp.2018.08.036Int J Radiat Oncol Biol Phys1032018"},{"key":"B44","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1097\/PRS.0b013e3182450b47","article-title":"Regulation of adipogenesis by lymphatic fluid stasis: part II. Expression of adipose differentiation genes","volume":"129","author":"Aschen","year":"2012","journal-title":"Plast Reconstr Surg"},{"key":"B45","unstructured":"Regulation of inflammation and fibrosis by macrophages in lymphedemaH106577 GhantaS CuzzoneDA TorrisiJS AlbanoNJ JosephWJ SavetskyIL 10.1152\/ajpheart.00598.201425724493Am J Physiol Heart Circ Physiol3082015"},{"key":"B46","doi-asserted-by":"publisher","first-page":"2620","DOI":"10.1002\/jcb.25557","article-title":"Adipose-derived stem cells support lymphangiogenic parameters in vitro","volume":"117","author":"Strassburg","year":"2016","journal-title":"J Cell Biochem"},{"key":"B47","unstructured":"Analysis of factors contributing to severity of breast cancer-related lymphedema225 CoriddiM KhansaI StephensJ MillerM BoehmlerJ TiwariP 10.1097\/SAP.0b013e31828d728523759971Ann Plast Surg742015"},{"key":"B48","unstructured":"Th2 differentiation is necessary for soft tissue fibrosis and lymphatic dysfunction resulting from lymphedema111426 AvrahamT ZampellJC YanA ElhadadS WeitmanES RocksonSG 10.1096\/fj.12-22269523193171FASEB J272013"},{"key":"B49","unstructured":"Interleukin-8 reduces post-surgical lymphedema formation by promoting lymphatic vessel regeneration2944 ChoiI LeeYS ChungHK ChoiD EcoiffierT LeeHN 10.1007\/s10456-012-9297-622945845Angiogenesis162013"},{"key":"B50","unstructured":"Cytokine candidate genes predict the development of secondary lymphedema following breast cancer surgery1022 LeungG BaggottC WestC ElboimC PaulSM CooperBA 10.1089\/lrb.2013.002424502445Lymphat Res Biol122014"},{"key":"B51","unstructured":"Microvascular filtration is increased in the forearms of patients with breast cancer-related lymphedema1927 JensenMR SimonsenL KarlsmarkT B\u00fclowJ 10.1152\/japplphysiol.01116.201223123353J Appl Physiol1142013"},{"key":"B52","unstructured":"Higher vascular endothelial growth factor-C concentration in plasma is associated with increased forearm capillary filtration capacity in breast cancer-related lymphedemae12403 JensenMR SimonsenL KarlsmarkT LanngC B\u00fclowJ 10.14814\/phy2.1240326059032Physiol Rep32015"},{"key":"B53","unstructured":"Functional recovery of fluid drainage precedes lymphangiogenesis in acute murine foreleg lymphedemaH22506 MendezU BrownEM OngstadEL SlisJR GoldmanJ 10.1152\/ajpheart.01159.201122427513Am J Physiol Heart Circ Physiol3022012"},{"key":"B54","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.breast.2016.04.011","article-title":"Risk factors for lymphoedema in women with breast cancer: a large prospective cohort","volume":"28","author":"Kilbreath","year":"2016","journal-title":"Breast"},{"key":"B55","unstructured":"Morbidity of sentinel node biopsy: relationship between number of excised lymph nodes and patient perceptions of lymphedema286672 GoldbergJI RiedelER MorrowM Van ZeeKJ 10.1245\/s10434-011-1688-121465310Ann Surg Oncol182011"},{"key":"B56","unstructured":"Risk factors for arm lymphedema in a cohort of breast cancer patients followed up for 10 years4550 VieiraRA da CostaAM de SouzaJL CoelhoRR de OliveiraCZ SarriAJ 10.1159\/00044248927051396Breast Care112016"},{"key":"B57","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1186\/s12885-018-4851-2","article-title":"Lymphovascular invasion and extranodal tumour extension are risk indicators of breast cancer related lymphoedema: an observational retrospective study with long-term follow-up","volume":"18","author":"Invernizzi","year":"2018","journal-title":"BMC Cancer"},{"key":"B58","unstructured":"Radiation therapy targets and the risk of breast cancer-related lymphedema: a systematic review and network meta-analysis20115 ShaitelmanSF ChiangYJ GriffinKD DeSnyderSM SmithBD SchaverienMV 10.1007\/s10549-016-4089-0Breast Cancer Res Treat1622017"},{"key":"B59","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1002\/bjs.9846","article-title":"Adjuvant taxanes and the development of breast cancer-related arm lymphoedema","volume":"102","author":"Cariati","year":"2015","journal-title":"Br J Surg"},{"key":"B60","unstructured":"Breast cancer systemic treatments and upper limb lymphedema: a risk-assessment platform encompassing tumor-specific pathological features reveals the potential role of trastuzumabE138 InvernizziM MichelottiA NoaleM LopezG RunzaL GirodaM 10.3390\/jcm802013830682851J Clin Med82019"},{"key":"B61","doi-asserted-by":"publisher","first-page":"S173","DOI":"10.1097\/SAP.0000000000001884","article-title":"The impact of taxane-based chemotherapy on the lymphatic system","volume":"82","author":"Johnson","year":"2019","journal-title":"Ann Plast Surg"},{"key":"B62","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1093\/annonc\/mdx308","article-title":"De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017","volume":"28","author":"Curigliano","year":"2017","journal-title":"Ann Oncol"},{"key":"B63","doi-asserted-by":"publisher","first-page":"2885","DOI":"10.1038\/sj.emboj.7600763","article-title":"Hepatocyte growth factor promotes lymphatic vessel formation and function","volume":"24","author":"Kajiya","year":"2005","journal-title":"EMBO J"},{"key":"B64","doi-asserted-by":"publisher","first-page":"3531","DOI":"10.1182\/blood-2005-06-2538","article-title":"Hepatocyte growth factor is a lymphangiogenic factor with an indirect mechanism of action","volume":"107","author":"Cao","year":"2006","journal-title":"Blood"},{"key":"B65","unstructured":"Transfection of human hepatocyte growth factor gene ameliorates secondary lymphedema via promotion of lymphangiogenesis117784 SaitoY NakagamiH MorishitaR TakamiY KikuchiY HayashiH 10.1161\/CIRCULATIONAHA.105.60295316952986Circulation1142006"},{"key":"B66","unstructured":"HGF and MET mutations in primary and secondary lymphedema658 FinegoldDN SchachtV KimakMA LawrenceEC FoeldiE KarlssonJM 10.1089\/lrb.2008.152418564920Lymphat Res Biol62008"},{"key":"B67","unstructured":"Connexin 47 mutations increase risk for secondary lymphedema following breast cancer treatment238290 FinegoldDN BatyCJ KnickelbeinKZ PerschkeS NoonSE CampbellD 10.1158\/1078-0432.CCR-11-230322351697Clin Cancer Res182012"},{"key":"B68","unstructured":"Possible genetic predisposition to lymphedema after breast cancer213 NewmanB LoseF KeddaMA FrancoisM FergusonK JandaM 10.1089\/lrb.2011.002422404826Lymphat Res Biol102012"},{"key":"B69","unstructured":"Lymphatic and angiogenic candidate genes predict the development of secondary lymphedema following breast cancer surgerye60164 MiaskowskiC DoddM PaulSM WestC HamolskyD AbramsG 10.1371\/journal.pone.006016423613720PLoS ONE82013"},{"key":"B70","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1016\/j.febslet.2014.01.011","article-title":"Connexins in lymphatic vessel physiology and disease","volume":"588","author":"Meens","year":"2014","journal-title":"FEBS Lett"},{"key":"B71","unstructured":"Potassium channel candidate genes predict the development of secondary lymphedema following breast cancer surgery8594 SmootB KoberKM PaulSM LevineJD AbramsG MastickJ 10.1097\/NNR.000000000000020328252570Nurs Res662017"},{"key":"B72","unstructured":"GJA4\/Connexin 37 mutations correlate with secondary lymphedema following surgery in breast cancer patientsE23 HadizadehM Mohaddes ArdebiliSM SalehiM YoungC MokarianF McClellanJ 10.3390\/biomedicines601002329470392Biomedicines62018"},{"key":"B73","unstructured":"Precision assessment of heterogeneity of lymphedema phenotype, genotypes and risk prediction23140 FuMR ConleyYP AxelrodD GuthAA YuG FletcherJ 10.1016\/j.breast.2016.06.02327460425Breast292016"},{"key":"B74","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/j.ejso.2004.02.008","article-title":"Variation in lymphatic function may predispose to development of breast cancer-related lymphoedema","volume":"30","author":"Pain","year":"2004","journal-title":"Eur J Surg Oncol"},{"key":"B75","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1046\/j.1365-2567.2002.01391.x","article-title":"T-cell antigen receptor signal transduction","volume":"105","author":"Cantrell","year":"2002","journal-title":"Immunology"},{"key":"B76","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1182\/blood-2010-02-270876","article-title":"Platelets regulate lymphatic vascular development through CLEC-2-SLP-76 signaling","volume":"116","author":"Bertozzi","year":"2010","journal-title":"Blood"},{"key":"B77","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1126\/science.1079477","article-title":"Regulation of blood and lymphatic vascular separation by signaling proteins SLP-76 and Syk","volume":"299","author":"Abtahian","year":"2003","journal-title":"Science"},{"key":"B78","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.devcel.2006.07.007","article-title":"Syk and Slp-76 mutant mice reveal a cell-autonomous hematopoietic cell contribution to vascular development","volume":"11","author":"Sebzda","year":"2006","journal-title":"Dev Cell"},{"key":"B79","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0925-4773(01)00518-4","article-title":"Differential expression of neuropilin-1 and neuropilin-2 in arteries and veins","volume":"109","author":"Herzog","year":"2001","journal-title":"Mech Dev"},{"key":"B80","doi-asserted-by":"crossref","first-page":"4797","DOI":"10.1242\/dev.129.20.4797","article-title":"Abnormal lymphatic vessel development in neuropilin 2 mutant mice","volume":"129","author":"Yuan","year":"2002","journal-title":"Development"},{"key":"B81","doi-asserted-by":"publisher","first-page":"266","DOI":"10.4161\/cam.5.3.16294","article-title":"Hypoxia induces tumor and endothelial cell migration in a semaphorin 3F- and VEGF-dependent manner via transcriptional repression of their common receptor neuropilin 2","volume":"5","author":"Coma","year":"2011","journal-title":"Cell Adh Migr"},{"key":"B82","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1002\/j.1460-2075.1996.tb00359.x","article-title":"A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases","volume":"15","author":"Joukov","year":"1996","journal-title":"EMBO J"},{"key":"B83","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1073\/pnas.93.5.1988","article-title":"Vascular endothelial growth factor-related protein: a ligand and specific activator of the tyrosine kinase receptor Flt4","volume":"93","author":"Lee","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"B84","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1182\/blood-2005-11-4447","article-title":"Neuropilin-2 interacts with VEGFR-2 and VEGFR-3 and promotes human endothelial cell survival and migration","volume":"108","author":"Favier","year":"2006","journal-title":"Blood"},{"key":"B85","doi-asserted-by":"publisher","first-page":"C343","DOI":"10.1152\/ajpcell.00048.2003","article-title":"VCAM-1-mediated Rac signaling controls endothelial cell-cell contacts and leukocyte transmigration","volume":"285","author":"van Wetering","year":"2003","journal-title":"Am J Physiol Cell Physiol"},{"key":"B86","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1039\/c4ib00201f","article-title":"The direction of migration of T-lymphocytes under flow depends upon which adhesion receptors are engaged","volume":"7","author":"Dominguez","year":"2015","journal-title":"Integr Biol"},{"key":"B87","doi-asserted-by":"publisher","first-page":"10132","DOI":"10.1073\/pnas.97.18.10132","article-title":"Retinoid-related orphan receptor \u03b3 (ROR\u03b3) is essential for lymphoid organogenesis and controls apoptosis during thymopoiesis","volume":"97","author":"Kurebayashi","year":"2000","journal-title":"Proc Natl Acad Sci"},{"key":"B88","doi-asserted-by":"publisher","first-page":"6831","DOI":"10.1038\/sj.onc.1209939","article-title":"Mutations in the NF-kappaB signaling pathway: implications for human disease","volume":"25","author":"Courtois","year":"2006","journal-title":"Oncogene"},{"key":"B89","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s10549-011-1855-x","article-title":"Role of interleukin-10 in breast cancer","volume":"133","author":"Hamidullah Changkija","year":"2012","journal-title":"Breast Cancer Res Treat"},{"key":"B90","doi-asserted-by":"publisher","first-page":"e52021","DOI":"10.1371\/journal.pone.0052021","article-title":"Prospective transcriptomic pathway analysis of human lymphatic vascular insufficiency: identification and validation of a circulating biomarker panel","volume":"7","author":"Lin","year":"2012","journal-title":"PLoS ONE"},{"key":"B91","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1007\/s10555-018-9734-0","article-title":"Roles of prostaglandins in tumor-associated lymphangiogenesis with special reference to breast cancer","volume":"37","author":"Lala","year":"2018","journal-title":"Cancer Metast Rev"},{"key":"B92","unstructured":"Connexin37 and Connexin43 deficiencies in mice disrupt lymphatic valve development and result in lymphatic disorders including lymphedema and chylothorax25366 KanadyJD DellingerMT MungerSJ WitteMH SimonAM 10.1016\/j.ydbio.2011.04.00421515254Dev Biol3542011"},{"key":"B93","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/j.devcel.2011.12.020","article-title":"Mechanotransduction, PROX1, and FOXC2 cooperate to control connexin37 and calcineurin during lymphatic-valve formation","volume":"22","author":"Sabine","year":"2012","journal-title":"Dev Cell"},{"key":"B94","unstructured":"GJC2 missense mutations cause human lymphedema9438 FerrellRE BatyCJ KimakMA KarlssonJM LawrenceEC Franke-SnyderM 10.1016\/j.ajhg.2010.04.01020537300Am J Hum Genet862010"},{"key":"B95","doi-asserted-by":"publisher","first-page":"8519","DOI":"10.1093\/nar\/gks630","article-title":"ROR\u03b3 directly regulates the circadian expression of clock genes and downstream targets in vivo","volume":"40","author":"Takeda","year":"2012","journal-title":"Nucleic Acids Res"},{"key":"B96","doi-asserted-by":"publisher","first-page":"3282","DOI":"10.4161\/15384101.2014.954454","article-title":"Loss of circadian clock gene expression is associated with tumor progression in breast cancer","volume":"13","author":"Cadenas","year":"2014","journal-title":"Cell Cycle"},{"key":"B97","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1210\/me.2013-1403","article-title":"PRMT2 and ROR\u03b3 expression are associated with breast cancer survival outcomes","volume":"28","author":"Oh","year":"2014","journal-title":"Mol Endocrinol"},{"key":"B98","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.ebiom.2016.02.028","article-title":"The nuclear receptor, ROR\u03b3, regulates pathways necessary for breast cancer metastasis","volume":"6","author":"Oh","year":"2016","journal-title":"EBioMedicine"},{"key":"B99","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1155\/2016\/9025905","article-title":"Connexin's connection in breast cancer growth and progression","volume":"2016","author":"Banerjee","year":"2016","journal-title":"Int J Cell Biol"},{"key":"B100","doi-asserted-by":"publisher","first-page":"646","DOI":"10.3389\/fonc.2018.00646","article-title":"Cancer connectors: connexins, gap junctions, and communication","volume":"8","author":"Sinyuk","year":"2018","journal-title":"Front Oncol"},{"key":"B101","doi-asserted-by":"publisher","first-page":"4429","DOI":"10.1038\/s41388-019-0741-6","article-title":"Connexins in cancer: bridging the gap to the clinic","volume":"38","author":"Aasen","year":"2019","journal-title":"Oncogene"},{"key":"B102","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s12929-019-0497-x","article-title":"Emerging roles of gap junction proteins connexins in cancer metastasis, chemoresistance and clinical application","volume":"26","author":"Wu","year":"2019","journal-title":"J Biomed Sci"},{"key":"B103","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1136\/jcp.2005.029272","article-title":"Increased expression of connexins 26 and 43 in lymph node metastases of breast cancer","volume":"59","author":"Kanczuga-Koda","year":"2006","journal-title":"J Clin Pathol"},{"key":"B104","doi-asserted-by":"publisher","first-page":"S175","DOI":"10.5603\/4481","article-title":"Increased expression of gap junction protein\u2013connexin 32 in lymph node metastases of human ductal breast cancer","volume":"45","author":"Kanczuga-Koda","year":"2007","journal-title":"Folia Histochem Cytobiol"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1007\/s40520-019-01436-8","article-title":"Myostatin as a potential biomarker to monitor sarcopenia in hip fracture patients undergoing a multidisciplinary rehabilitation and nutritional treatment: a preliminary study. Aging","author":"de Sire","year":"2019","journal-title":"Clin Exp Res."},{"key":"B106","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1097\/cco.0000000000000006","article-title":"Current status of interleukin-10 and regulatory T-cells in cancer","volume":"25","author":"Dennis","year":"2013","journal-title":"Curr Opin Oncol"},{"key":"B107","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1007\/s00432-010-0839-2","article-title":"Analysis of common germline polymorphisms as prognostic factors in patients with lymph node-positive breast cancer","volume":"136","author":"Knechtel","year":"2010","journal-title":"J Cancer Res Clin Oncol"},{"key":"B108","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1186\/s12885-018-4044-z","article-title":"Tumour-draining axillary lymph nodes in patients with large and locally advanced breast cancers undergoing neoadjuvant chemotherapy (NAC): the crucial contribution of immune cells (effector, regulatory) and cytokines (Th1, Th2) to immune-mediated tumour cell death induced by NAC","volume":"18","author":"Kaewkangsadan","year":"2018","journal-title":"BMC Cancer"},{"key":"B109","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.currproblcancer.2018.01.009","article-title":"IL-10 correlates with the expression of carboxypeptidase B2 and lymphovascular invasion in inflammatory breast cancer: the potential role of tumor infiltrated macrophages","volume":"42","author":"Mohamed","year":"2018","journal-title":"Curr Probl Cancer"},{"key":"B110","unstructured":"A pilot study of vascular endothelial growth factor inhibition with bevacizumab in patients with lymphedema following breast cancer treatment9523 MillerK ChristmonD PerkinsS SunJ SchneiderB StornioloA 10.1200\/jco.2009.27.15_suppl.9523J Clin Oncol272009"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fonc.2020.00422\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,3]],"date-time":"2024-08-03T04:04:27Z","timestamp":1722657867000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fonc.2020.00422\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,2]]},"references-count":110,"alternative-id":["10.3389\/fonc.2020.00422"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2020.00422","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,2]]},"article-number":"422"}}